Concepedia

M.G. Schlieman

MS

5

Publications

501

Citations

5

H-Index

2003

Active since

Affiliations

University of California, Davis(Current)

University of California Davis Medical Center

M.G. Schlieman is an author at University of California, Davis specializing in medicine, cancer research, and radiation oncology.

Top concepts

Publications per year

2003–2004

5

Publications

5

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

M.G. Schlieman, Bridget N. Fahy, Rajendra Ramsamooj et al. · British Journal of Cancer · 2003 · 254 citations · Full text

AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2

Bridget N. Fahy, M.G. Schlieman, S. Virudachalam et al. · British Journal of Cancer · 2003 · 112 citations · Full text

, , +16

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

MelindaM. Mortenson, M.G. Schlieman, Subbulakshmi Virudachalam et al. · Cancer Chemotherapy and Pharmacology · 2004 · 101 citations

, , +6

Overexpression of BCL-2 results in activation of the AKT/NF-kB Cell survival pathway

Melinda M. Mortenson, M.G. Schlieman, S. Virudalchalam et al. · Journal of Surgical Research · 2003 · 19 citations

, , +11

Targeting NF-kB/BCL-2 pathway increases apoptotic susceptibility to chemotherapy in pancreatic cancer

Joseph M. Galante, Melinda M. Mortenson, M.G. Schlieman et al. · Journal of Surgical Research · 2004 · 15 citations

, , +6

Rows per page

1–5 of 5